Supplier to the pharma, biotech and specialty ingredients markets, Lonza, has expanded its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in the US.
The World Health Organisation (WHO) has released figures highlighting a startling 400% increase in cases of measles reported in 2017 compared with the previous year’s figures.
A co-founder of the company ApconiX, based in Alderley Park, has revealed his view that attitude towards safety in pre-clinical cancer drug development needs to change.
According to Catalyst Corporate Finance, UK service-based pharma businesses involved in ‘smart’ areas of the market are experiencing heightened interest from domestic and international acquirers.
Various aspects must be considered when deciding upon the best coating technology. Here, the authors describe their recent study comparing three different coating technologies’ efficiency in a pellet coating process.
Data and analytics company, GlobalData, has revealed its prediction that Merck will lead the way in licensing deals for the year when considering the success of the company since 2016.
Today (Friday 9 Feburary 2018) marks the precise point that we are a year away until the European Union Falsified Medicines Directive (EU FMD) comes into force. Here, we feature some expert opinions
The MedTalk Podcast returns with its first episode of 2018, looking at the biggest and most topical news of the year so far in the digital health, pharma, medical plastics and med-tech spaces.
Drug research and development is often likened to finding a needle in a haystack with multiple targets and many potential variables with which they can interact. So, what technological advancements are impacting development timelines…
